Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study.

MLA

Sütçü, Murat, et al. “Hand, Foot, and Mouth Disease: Could EPs® 7630 Be a Treatment Option? A Prospective Randomized Open-Label Multicenter Clinical Study.” Frontiers in Pediatrics, vol. 12, May 2024, p. 1274010. EBSCOhost, https://doi.org/10.3389/fped.2024.1274010.

APA

Sütçü, M., Kara, M., Yıldız, F., Kılıç, Ö., Tural Kara, T., Akkoc, G., Büyükçam, A., Elmas Bozdemir, Ş., Özgür Gündeşlioğlu, Ö., Gül, D., İseri Nepesov, M., & Kara, A. (2024). Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study. Frontiers in Pediatrics, 12, 1274010. https://doi.org/10.3389/fped.2024.1274010

Chicago

Sütçü, Murat, Manolya Kara, Funda Yıldız, Ömer Kılıç, Tugce Tural Kara, Gulsen Akkoc, Ayşe Büyükçam, et al. 2024. “Hand, Foot, and Mouth Disease: Could EPs® 7630 Be a Treatment Option? A Prospective Randomized Open-Label Multicenter Clinical Study.” Frontiers in Pediatrics 12 (May): 1274010. doi:10.3389/fped.2024.1274010.